Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-06-02 @ 2:13 PM
Study NCT ID:
NCT07470203
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-13
First Post:
2026-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer
Sponsor:
Organization: